Clinical Trial Update: Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Symbicort (budesonide/formoterol) with Pulmicort Flexhaler (budesonide) in African Americans with asthma has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PULMICORT FLEXHALER (BUDESONIDE)
• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2012-11-09